Intrinsic Imaging

ISO 13485 Certified Imaging Core Lab

Intrinsic Imaging’s quality management system is certified to ISO 13485 by the British Standards Institution (BSI), with a scope covering imaging core lab services for clinical trials.

Intrinsic Imaging does not manufacture devices. It holds the device manufacturers’ standard because the imaging endpoints it produces are the clinical evidence on which a 510(k), De Novo or PMA decision rests, and a device sponsor deserves an imaging core lab that works to the same discipline as its own quality system.

Under that certification, Intrinsic Imaging delivers reading software validated before it measures a single case, readers qualified and trained on the specific protocol they read, and endpoints traceable back to the images each site acquired, giving the sponsor imaging evidence that holds up to the same scrutiny as the device itself.

What Intrinsic Imaging Provides to Device Sponsors

Faster Qualification of a Critical Supplier

A device sponsor must evaluate its suppliers and control them in proportion to the risk their work carries, and an imaging core lab producing the primary effectiveness endpoint is among the highest-risk suppliers a device program has. Intrinsic Imaging provides a certificate from an accredited body, a quality system organized the same way as the sponsor's own and an established audit history. Supplier qualification becomes a review of existing evidence rather than an extended custom audit and the creation of new evidence.

Validated Measurement Tools

Device trials often depend on quantitative outputs such as angular measurements of spinal alignment, migration distance of a hip stem, minimal luminal diameter of a coronary stent or segmented ablation volume. Intrinsic Imaging validates each measurement tool for its intended use against reference data or phantoms, ties the validation to a specific software version, and performs a risk assessment, with revalidation where warranted, whenever the software changes. The sponsor can show a regulator not only the measurement but the evidence that the tool producing it was fit for purpose at the time.

A Defined Path for Device-Relevant Findings

A blinded reader may be the first to see a lead fracture, a migrated filter, a stent fracture or an unexpected fluid collection next to an implant. Intrinsic Imaging does not file the medical device report or vigilance report, but it operates a documented path by which such an observation reaches the sponsor within a defined time, with a record of what was seen, when, by whom and when the sponsor was told. The sponsor's own reporting deadline is not put at risk by an undocumented delay.

Traceable, Device-Grade Imaging Evidence

Every image, read and measurement is identified and traceable, readers are trained with confirmed effectiveness, risk management is applied throughout the work, and nonconforming output is controlled. Whether the endpoint is fusion status on CT, migration or subsidence on radiographs, in-stent restenosis on angiography, ablation zone on MRI or an imaging AI algorithm's performance against a reference standard, it is produced under the controls a device submission requires.

Why Device Sponsors Choose Intrinsic Imaging

The imaging core lab is part of a device sponsor's design validation, and the sponsor remains accountable for the quality of every part of the clinical evidence in its submission, including the parts its core lab produces.

Intrinsic Imaging's ISO 13485 certification meets that obligation directly. The sponsor can rely on an accredited certification against the same standard it is audited to, rather than on a custom audit of a core lab running a general-purpose quality system, and the imaging endpoints are produced under the same process and software validation requirements the sponsor applies to itself. The evidence in a 510(k), De Novo or PMA submission is therefore no weaker at the point where imaging enters it. Intrinsic Imaging's quality systems have been examined in three FDA Bioresearch Monitoring Program inspections, each of which closed with zero Form FDA 483 observations.

The Standard Behind the Service

ISO 13485 is the international standard for quality management in the medical device industry, and the United States Food and Drug Administration has incorporated it by reference into its Quality Management System Regulation. Compared with ISO 9001, it builds regulatory requirements into the quality system, requires risk management throughout, requires software used in service delivery to be validated before use and after changes, and treats the prevention of problems that have not yet occurred as a separate obligation. Intrinsic Imaging holds both certifications.

Frequently Asked Questions

Does Intrinsic Imaging disclose its sub-processors and data locations?
Yes. Before processing begins, Intrinsic Imaging discloses its sub-processors, such as the cloud hosting provider, and the countries in which personal data may be stored, with notice of any change.
Can I discuss an upcoming trial with Intrinsic Imaging outside a conference?
Yes. Contact Intrinsic Imaging through the Contact Us page, by email at [email protected] or by phone at +1 978-616-4650 to discuss imaging for an upcoming trial.
Who reviews gastroenterology trial data at Intrinsic Imaging?
Intrinsic Imaging’s gastroenterology trial data are reviewed by more than 35 board-certified, fellowship-trained gastroenterologists.
Go to more Frequently Asked Questions

Tell us about your trial.

Our team will respond within one business day.